Application 202111
- Type
- ANDA
- Sponsor
- HOSPIRA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | INJECTABLE;INJECTION | 100MG | No | No |
| 002 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | INJECTABLE;INJECTION | 500MG | No | No |
| 003 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | POWDER;INTRAVENOUS | EQ 1GM BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 82012-027 | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | Senores Pharmaceuticals, Inc. | ANDA | Current |